LivaNova (LIVN) Competitors $35.07 +0.27 (+0.78%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LIVN vs. STVN, GKOS, NARI, INSP, BLCO, SLNO, IRTC, PRCT, NVST, and TMDXShould you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. LivaNova vs. Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb Soleno Therapeutics iRhythm Technologies PROCEPT BioRobotics Envista TransMedics Group LivaNova (NASDAQ:LIVN) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings. Which has higher valuation and earnings, LIVN or STVN? Stevanato Group has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLivaNova$1.25B1.52$17.55M$1.1430.66Stevanato Group$1.10B6.02$157.62M$0.4845.75 Does the media prefer LIVN or STVN? In the previous week, LivaNova had 10 more articles in the media than Stevanato Group. MarketBeat recorded 16 mentions for LivaNova and 6 mentions for Stevanato Group. LivaNova's average media sentiment score of 1.28 beat Stevanato Group's score of 1.22 indicating that LivaNova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 10 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Stevanato Group 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor LIVN or STVN? LivaNova received 375 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 69.71% of users gave LivaNova an outperform vote while only 62.50% of users gave Stevanato Group an outperform vote. CompanyUnderperformOutperformLivaNovaOutperform Votes40569.71% Underperform Votes17630.29% Stevanato GroupOutperform Votes3062.50% Underperform Votes1837.50% Do institutionals & insiders believe in LIVN or STVN? 97.6% of LivaNova shares are owned by institutional investors. 0.3% of LivaNova shares are owned by insiders. Comparatively, 0.7% of Stevanato Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is LIVN or STVN more profitable? Stevanato Group has a net margin of 10.47% compared to LivaNova's net margin of 1.91%. LivaNova's return on equity of 13.81% beat Stevanato Group's return on equity.Company Net Margins Return on Equity Return on Assets LivaNova1.91% 13.81% 7.07% Stevanato Group 10.47%9.86%5.79% Do analysts prefer LIVN or STVN? LivaNova currently has a consensus price target of $61.17, suggesting a potential upside of 75.01%. Given LivaNova's stronger consensus rating and higher possible upside, analysts clearly believe LivaNova is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivaNova 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.88Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71 Which has more volatility & risk, LIVN or STVN? LivaNova has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. SummaryLivaNova beats Stevanato Group on 14 of the 18 factors compared between the two stocks. Remove Ads Get LivaNova News Delivered to You Automatically Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIVN vs. The Competition Export to ExcelMetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.90B$3.10B$5.30B$7.36BDividend YieldN/A1.80%5.11%4.32%P/E Ratio83.2114.6621.6917.67Price / Sales1.5243.57371.5292.57Price / Cash11.1544.0938.1534.64Price / Book1.473.256.373.94Net Income$17.55M$94.03M$3.20B$247.37M7 Day Performance-2.16%-3.83%1.91%0.64%1 Month Performance-10.93%-9.82%-9.32%-6.98%1 Year Performance-34.28%-22.53%9.64%-0.32% LivaNova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIVNLivaNova3.5606 of 5 stars$35.07+0.8%$61.17+74.4%-34.8%$1.91B$1.25B83.502,900Positive NewsSTVNStevanato Group1.7327 of 5 stars€19.23+1.1%N/A-23.5%$5.82B$1.10B40.914,650Positive NewsGKOSGlaukos4.5562 of 5 stars$85.87+2.7%$163.25+90.1%-2.4%$4.86B$383.48M-29.92780Analyst ForecastNews CoverageHigh Trading VolumeNARIInari Medical0.3435 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800INSPInspire Medical Systems4.6416 of 5 stars$149.72+5.5%$226.70+51.4%-34.3%$4.46B$802.80M86.541,246Analyst ForecastNews CoveragePositive NewsGap UpBLCOBausch + Lomb3.8736 of 5 stars$11.86-2.1%$18.82+58.7%-16.5%$4.18B$4.79B-13.0312,500Gap UpSLNOSoleno Therapeutics4.7799 of 5 stars$69.64+3.2%$99.63+43.1%+82.4%$3.19BN/A-20.9830Analyst ForecastPositive NewsHigh Trading VolumeIRTCiRhythm Technologies1.0195 of 5 stars$100.17-0.2%$119.73+19.5%-8.0%$3.15B$591.84M-27.521,790Positive NewsPRCTPROCEPT BioRobotics2.3921 of 5 stars$50.83-0.8%$94.29+85.5%+4.6%$2.79B$224.50M-26.07430Positive NewsHigh Trading VolumeNVSTEnvista4.3739 of 5 stars$15.27-1.4%$20.18+32.2%-21.0%$2.63B$2.51B-2.3512,700Analyst ForecastAnalyst RevisionNews CoverageTMDXTransMedics Group2.751 of 5 stars$69.15+2.2%$122.70+77.4%-5.1%$2.33B$441.54M73.56210 Remove Ads Related Companies and Tools Related Companies STVN Alternatives GKOS Alternatives NARI Alternatives INSP Alternatives BLCO Alternatives SLNO Alternatives IRTC Alternatives PRCT Alternatives NVST Alternatives TMDX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIVN) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.